John Koconis - 15 Apr 2022 Form 4 Insider Report for Timber Pharmaceuticals, Inc.

Role
CEO & Chairman of the Board, Director
Signature
/s/ Joseph Lucchese, Power of Attorney
Issuer symbol
N/A
Transactions as of
15 Apr 2022
Net transactions value
$0
Form type
4
Filing time
19 Apr 2022, 13:01:07 UTC
Previous filing
16 Dec 2021
Next filing
18 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMBR Stock Option (right to buy) Award $0 +600,000 $0.000000 600,000 15 Apr 2022 Common Stock, par value $0.001 per share 600,000 $0.3070 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the options vest on April 15, 2023, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2023, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.